Follow
Gagandeep Singh
Title
Cited by
Cited by
Year
Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine
F Krammer, K Srivastava, H Alshammary, AA Amoako, MH Awawda, ...
New England Journal of Medicine 384 (14), 1372-1374, 2021
8042021
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
JM Carreño, H Alshammary, J Tcheou, G Singh, AJ Raskin, H Kawabata, ...
Nature 602 (7898), 682-688, 2022
4502022
SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
K Sano, D Bhavsar, G Singh, D Floda, K Srivastava, C Gleason, ...
Nature Communications 13 (1), 5135, 2022
792022
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains
B Ying, B Whitener, LA VanBlargan, AO Hassan, S Shrihari, CY Liang, ...
Science translational medicine 14 (630), eabm3302, 2021
662021
mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations
JM Carreño, G Singh, J Tcheou, K Srivastava, C Gleason, H Muramatsu, ...
Vaccine 40 (42), 6114-6124, 2022
402022
Morphometric analysis of foramen magnum in human skull for sex determination
G Singh, I Talwar
Human biology review 2 (1), 29-41, 2013
392013
Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients
JM Carreño, H Alshammary, G Singh, A Raskin, F Amanat, A Amoako, ...
EBioMedicine 73, 2021
382021
Safety and immunogenicity of a newcastle disease virus vector-based SARS-CoV-2 vaccine candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs
JH Lara-Puente, JM Carreño, W Sun, A Suárez-Martínez, ...
MBio 12 (5), 10.1128/mbio. 01908-21, 2021
352021
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study
A Ozonoff, J Schaenman, ND Jayavelu, CE Milliren, CS Calfee, CB Cairns, ...
EBioMedicine 83, 2022
332022
Determination of gender differences from fingerprints ridge density in two northern Indian population of Chandigarh region
G Singh
J. Forensic Res 3 (03), 3, 2012
222012
Bivalent COVID-19 booster vaccines and the absence of BA. 5-specific antibodies
JM Carreño, G Singh, V Simon, F Krammer
The Lancet Microbe 4 (8), e569, 2023
202023
Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice
I González-Domínguez, JL Martínez, S Slamanig, N Lemus, Y Liu, TY Lai, ...
Microbiology Spectrum 10 (3), e01538-22, 2022
192022
Analysis of ANKKI (rs1800497) and DRD2 (rs1079597, rs1800498) variants in five ethnic groups from Punjab, North-West India
G Singh, I Talwar, R Sharma, HS Sandhu, K Matharoo, AJS Bhanwer
Gene 584 (1), 69-74, 2016
172016
Safety and immunogenicity analysis of a Newcastle disease virus (NDV-HXP-S) expressing the spike protein of SARS-CoV-2 in sprague dawley rats
J Tcheou, A Raskin, G Singh, H Kawabata, D Bielak, W Sun, ...
Frontiers in Immunology 12, 791764, 2021
162021
Genetic differentiation and population structure of five ethnic groups of Punjab (North-West India)
G Singh, I Talwar, R Sharma, K Matharoo, AJS Bhanwer
Molecular Genetics and Genomics 291, 2055-2063, 2016
152016
Identification of selected wild felids using hair morphology and forensically informative nucleotide sequencing (FINS): Wildlife forensics prospective
G Singh, Y Srinivas, GC Kumar, A Singh, CP Sharma, SK Gupta
Legal Medicine 44, 101692, 2020
122020
Longitudinal analysis of severe acute respiratory syndrome coronavirus 2 seroprevalence using multiple serology platforms
FK Juan Manuel Carreño, Damodara Rao Mendu, Viviana Simon, Masood A Shariff ...
iScience 24 (9), 1-12, 2021
82021
SARS-CoV-2 spike-binding antibody longevity and protection from reinfection with antigenically similar SARS-CoV-2 variants
J Kubale, C Gleason, JM Carreño, K Srivastava, G Singh, A Gordon, ...
MBio, 2022
62022
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants
S Changrob, PJ Halfmann, H Liu, JL Torres, JJC McGrath, G Ozorowski, ...
The Journal of Clinical Investigation 133 (8), 2023
52023
Binding and avidity signatures of polyclonal sera from individuals with different exposure histories to severe acute respiratory syndrome coronavirus 2 infection, vaccination …
G Singh, A Abbad, J Tcheou, DR Mendu, A Firpo-Betancourt, C Gleason, ...
The Journal of Infectious Diseases 228 (5), 564-575, 2023
42023
The system can't perform the operation now. Try again later.
Articles 1–20